Associated Papers
Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
Al-Shinnag M et al.
Pathology, 2024
RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC.
Xu J et al.
International Journal of Molecular Sciences, 2023
Select a paper to view details